Raymond James Bullish on Dianthus as Claseprubart Outperforms Expectations in Early CAPTIVATE Results

Raymond James reiterated its Strong Buy rating and $125 price target on Dianthus after the company reported strong early data from the Phase 3 CAPTIVATE study of claseprubart in CIDP.